To buy shares in United Therapeutics Corporation you will need a US based stock trading platform like Interactive Brokers, eToro or Moomoo where it currently costs $303.57 to buy one share in United Therapeutics Corporation (as of 13:53 19-May-2025). Which is a change of $-2.11 or 0.27% from the last closing price of $305.35.
How To Buy United Therapeutics Corporation Stock
It may seem complicated to buy stock for the first time, but it’s actually very easy. Follow these simple steps to buy shares in United Therapeutics Corporation:
- Pick a stock broker (jump down to compare the best brokers for buying United Therapeutics Corporation stock)
- Deposit funds (bank transfer, ACH, wire transfer, or card)
- Search for the stock symbol: (NASDAQ:UTHR)
- Choose the number of shares you want to buy (1 share currently costs $303.57)
- Click buy (you can either trade immediately at “market” or set a “limit” to buy the stock cheaper if you think the price will go down)
- Track the performance of your United Therapeutics Corporation stock in your account (this will show your profit and loss)
United Therapeutics Corporation Share Price (UTHR) Quote & Overview
This section shows the most important aspects of the current United Therapeutics Corporation UTHR:US share price including price, change, bid/offer spread and volume.
- United Therapeutics Corporation is currently worth $13,678,134,040 based on the last closing price of $305.35 with 249,219 shares traded.
- The most recent United Therapeutics Corporation daily high has been $306.13 and daily low $300.51.
- The United Therapeutics Corporation stock price 52 week high has been $417.82 and the 52 week low $264.33.
Compare Brokers For Buying United Therapeutics Corporation Stock
Is Now A Good Time To Buy United Therapeutics Corporation Stock?
- United Therapeutics Corporation’s EPS (earnings per share) are 25.08. A high EPS indicates strong profitability but may already be priced in, while a low EPS could signal weak earnings or a turnaround opportunity, requiring industry comparison.
- United Therapeutics Corporation’s PE (price earnings ratio) is 12.09. A low PE ratio may suggest undervaluation but could also indicate slow growth or risk, whereas a high PE ratio reflects high growth expectations but may signal overvaluation, necessitating a check on earnings sustainability.
The below United Therapeutics Corporation share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.
United Therapeutics Corporation (UTHR) Analysis
This section shows analysis for United Therapeutics Corporation UTHR:US. It shows analyst rating, recommnedations and history, as well industry ranking comparison.
United Therapeutics Corporation (UTHR) Earnings Estimates & Forecasts
This section shows how analysts expect the United Therapeutics Corporation UTHR:US share price to perform in the future based on their earnings reports and estimates. It gives an overview of future short, long and medium term price targets as well as previous earnings reports.
United Therapeutics Corporation (UTHR) Company Financials
This section shows current and previous United Therapeutics Corporation UTHR:US profit and loss information like revenue, income, expenses and earnings per share.
United Therapeutics Corporation (UTHR) Financial Summary
This section allows you to compare United Therapeutics Corporation UTHR:US revenue, net income, cash flow statement and balance sheet against previous years. This can give you a good indication of how well a company is performing.
United Therapeutics Corporation (UTHR) Share Price History
This section provides a visual and table view of the historic United Therapeutics Corporation UTHR:US share price including volume and VWAP which can be adjusted for splits and dividends.
United Therapeutics Corporation (UTHR) Interactive Chart
This section allows you to compare United Therapeutics Corporation UTHR:US share price chart against other stocks as well as overlay key events like dividends, earnings and splits.
United Therapeutics Corporation (UTHR) Dividends
This section analyses the historic and upcoming United Therapeutics Corporation UTHR:US dividend amounts, dates and yields. It provides a good indication of potential future and past profitability.
United Therapeutics Corporation (UTHR) Corporate Events
This section shows key dates in United Therapeutics Corporation UTHR:US corporate calendar like company announcements, earnings releases, stock splits, and fundamental data chances like EPS updates.
United Therapeutics Corporation (UTHR) Share Price Performance
This section shows key United Therapeutics Corporation UTHR:US share price levels like recent highs and lows, plus gives you tools to see average day traded volumes and institutional share holders major buys and sells.
United Therapeutics Corporation (UTHR) Share Price News
This section shows new stories that are relevant to and may effect or explain changes in United Therapeutics Corporation UTHR:US share price.
United Therapeutics Corporation (UTHR) Company Profile
This section provides corporate information on United Therapeutics Corporation UTHR:US, including what they do, their contact details, their CEO and auditor as well as in what sectors their shares trade.